Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07197892 · ClinicalTrials.gov registry record · NA
Conversational AI Platform for Early Pregnancy Care City-wide Recruitment: A Feasibility Study
A NA study, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 2,637
- Enrollment target
NCT07197892: Recruiting NA study, sponsored by University of Pennsylvania.
NCT07197892 is a NA study that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 2,637 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07197892, a NA study, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,637 participants
- Enrollment target
Study Summary
This study seeks to determine pregnant patients in the Philadelphia area can be recruited to a conversational AI texting platform. The trial will be considered feasible if recruitment goals are met in proportion to delivery volume at the hospital.
Primary Outcome
Proportion of pregnant patients in Philadelphia who sign up to use CIRCA texting platform
Interventions
- OTHER CIRCA Texting Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,637 participants |
| Start Date | 2026-04-06 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT07197892 shows while recruiting
NCT07197892 is an interventional study that assigns participants to a tested intervention. Its 2,637 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher).
The record links to 0 conditions, and to 1 intervention - of which CIRCA Texting Platform is the first listed.
NCT07197892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07197892 about?
NCT07197892 is a clinical study titled "Conversational AI Platform for Early Pregnancy Care City-wide Recruitment: A Feasibility Study". This study seeks to determine pregnant patients in the Philadelphia area can be recruited to a conversational AI texting platform. The trial will be considered feasible if recruitment goals are met in proportion to delivery volume at the hospital.
What is the current status of trial NCT07197892?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,637 participants. The study started on 2026-04-06. Estimated completion is 2027-09.
What interventions are being tested in trial NCT07197892?
The interventions under investigation include: CIRCA Texting Platform (OTHER).
Who is sponsoring clinical trial NCT07197892?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07197892's enrollment target sits among peer trials
2,637 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI